Heron Therapeutics Inc vs PayPal Holdings, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while PayPal Holdings, Inc. trades at $55.96 (market cap $50.12B). The key difference: PayPal Holdings, Inc. is far larger — about 548× Heron Therapeutics Inc's market cap, and PayPal Holdings, Inc. pays a 0.99% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PYPL | |
|---|---|---|
Market Cap | $91.46M | $50.12B |
Sector | Health | Financials |
52-Week High | $1.96 | $78.22 |
52-Week Low | $0.39 | $39.08 |
Enterprise Value | $189.36M | $50.19B |
Dividend Yield | — | 0.99% |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →